Picture of Medpacto logo

235980 Medpacto Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Annual cashflow statement for Medpacto, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsARSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-25,352-17,040-35,753-35,325-20,140
Depreciation
Amortisation
Non-Cash Items-66.5-9,4721,0857,784-1,009
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital600-3653,189-5933,048
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-23,382-25,153-29,614-26,301-16,559
Capital Expenditures-811-909-925-173-323
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items26,940-76,85826,68896,699-39,915
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities26,129-77,76625,76396,526-40,237
Financing Cash Flow Items-24.434-150
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-60.4101,5232,8982,014-844
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2,519-1,399-93372,244-57,595